<ul data-eligibleForWebStory="false"><li>Apple is urging the United States Court of Appeals to overturn a 2023 ITC ruling that required the company to remove blood-oxygen monitoring features from its Apple Watch to avoid an import ban.</li><li>Apple complied with the ruling in 2024, disabling blood-oxygen monitoring on newer Apple Watch models due to infringement on pulse-oximetry patents held by Masimo.</li><li>Representatives from Apple and Masimo presented arguments in front of a three-judge panel, with Apple claiming the ban deprived millions of users of critical health features.</li><li>The legal battle between Apple and Masimo dates back to 2020, with Masimo suing Apple over blood-oxygen level technology in the Apple Watch Series 6, leading to ongoing disputes and appeals.</li></ul>

Apple and Masimo present arguments to U.S. Court of Appeals over blood-oxygen tech-related import ban

Discover more